Two companies are under investigation by the Health Sciences Authority (HSA) for their claims on treatments to cure myopia, following complaints from customers.

HSA told TODAY on Wednesday (25 November) that its investigations against SLM Visioncare and ICC Visioncare are based on possible violations of the Health Products (Medical Devices) Regulations.

SLM Visioncare is also being investigated by the Ministry of Health (MOH) after it received six complaints against the firm, said the ministry.

According to SLM Visioncare’s website, it harnesses physiotherapy to “improve the blood circulation and elasticity” of ciliary muscles in the eyes. The ciliary muscles are responsible for controlling the focus of the eyes.

The method, the company claimed, will help patients heal from myopia with no adverse side effects.

SLM Visioncare also claimed that its therapies are “especially effective” for children aged between six and 16.

Also read: Netizens urge MOM to conduct proper investigation following M’sian woman’s alleged suicide due to workplace bullying at eye therapy firm

Subscribe
Notify of
3 Comments
Newest
Oldest Most Voted
Inline Feedbacks
View all comments
You May Also Like

TraceTogether bags international award for innovation despite not meeting Govt minimum uptake target for entering Phase 3 of post-circuit breaker reopening

Singapore’s TraceTogether on Monday (7 December) emerged as the Asia-Pacific winner of…

New stricter measures may not have a major impact but will “buy time”: Prof Paul Tambyah

Infectious diseases expert Professor Paul Tambyah says that while the measures may…